Skip to main content


Scientific Name(s): Myristica fragrans Houtt.
Common Name(s): Nutmeg, mace, magic, muscdier, nux moschata, myristica oil, muskatbaum

Medically reviewed by Last updated on Nov 21, 2022.

Clinical Overview


Nutmeg and mace, widely accepted as flavoring agents, have been used in higher doses for their aphrodisiac and psychoactive properties.


There are no clinical trials to support therapeutic dosing. Consumption of nutmeg at 1 to 2 mg/kg body weight was reported to induce CNS effects. Toxic overdose occurred at a 5 g dose.


Contraindications have not been identified. The excessive use of nutmeg or mace is not recommended in people with psychiatric conditions.


Generally recognized as safe when used in food as a flavoring agent. Safety for doses above those found in foods is unproven; avoid because of possible abortifacient effects.


None well documented.

Adverse Reactions

Allergy, contact dermatitis, and asthma have been reported.


CNS excitation with anxiety/fear, cutaneous flushing, decreased salivation, GI symptoms, and tachycardia. Acute psychosis and anticholinergic-like episodes have been documented; death has rarely been reported following the ingestion of large doses of nutmeg.

Scientific Family

  • Myristicaceae


Mace and nutmeg are 2 slightly different flavored spices, both originating from the fruit of the nutmeg tree, Myristica fragrans. This slow-growing evergreen grows to more than 20 m and is cultivated in India, Ceylon, Malaysia, and Granada. The fruit, which is called a drupe or a nutmeg apple, is similar in appearance to a peach or an apricot. When the mature fruit splits open, the nutmeg (stony endocarp or seed surrounded by a red, slightly fleshy network or aril) is exposed. The dried aril alone is called mace. The nut is removed and dried to produce nutmeg.1, 2, 3


Nutmeg is a widely used food spice that has received attention as an alternative hallucinogen. Nutmeg and mace have been used in Indian cooking and folk medicine. In folk medicine, nutmeg has been used to treat gastric disorders and rheumatism, and also as a hypnotic and an aphrodisiac. During the 6th century AD, nutmeg and mace were imported by Arab traders, and by the 12th century, they were well known in Europe. At the turn of the 19th century, interest developed in the use of nutmeg as an abortifacient and a stimulant for menses. These properties have been largely discounted but remain a persistent cause of nutmeg intoxication in women.2, 3, 4


Nutmeg seeds contain 20% to 40% of a fixed oil commonly called nutmeg butter. This oil contains myristic acid, trymiristin, and glycerides of lauric, tridecanoic, stearic, and palmitic acids.5, 6 Nutmeg also yields 8% to 15% of an essential oil that is believed to be partially responsible for the effects associated with nutmeg intoxication. The essential oil contains myristicin, elemicin, eugenol, and safrole.5, 6, 7 The essential oils of nutmeg and mace are very similar in chemical composition and aroma, with wide color differences (brilliant orange to pale yellow). Mace oil appears to have a higher myristicin content than nutmeg oil.8

Also present in the oil are sabinene, cymene, alpha-thujene, gamma-terpinene, and monoterpene alcohols in smaller amounts. Phenolic compounds found in nutmeg are reported to have antioxidant properties.6, 7, 9, 10, 11 Other isolated compounds include the resorcinols malabaricone B and C12 as well as lignans and neolignans.13, 14, 15

Uses and Pharmacology

There are no relevant clinical trials reported in the literature for nutmeg or mace.

Antimicrobial effects

The oils of mace and nutmeg and their individual components (trimyristin, myristic acid, myristin, mace lignan) have been assessed for in vitro activity, which has been shown against some oral microorganisms(42, 43); however, activity against other human pathogens has been demonstrated in vitro.(44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54) A modulatory effect on the protein/toxins produced by some bacteria, but not on the microorganisms themselves, has also been described.(42, 44, 45, 46) Reports of activity against fungi are conflicting.(55, 56, 57) The crude extract of M. fragrans (aril or leaf) was found to have strong inhibitory activity on Helicobacter pylori in vitro with a minimal inhibitory concentration (MIC) of 12.5 mcg/mL; leaf extract had a MIC of 50 mcg/mL. Amoxicillin (MIC range, 0.0039 to 0.25 mcg/mL) and metronidazole (MIC range, 64 to 124 mcg/mL) were used as controls.(79)

Antioxidant effects

Experiments have evaluated the antioxidant potential of the oils of nutmeg and mace and their chemical components. Eugenol and mace lignans, as well as the phenolic content, have been identified as components of nutmeg with antioxidant activity, and inhibition of nitric oxide production, NO-scavenging, and decreased LDL-oxidation were demonstrated in experiments.(6, 10, 15, 58, 59, 60, 61, 62, 63, 64)

Aphrodisiac effects

Animal data

Increased sexual activity (libido and potency) has been demonstrated in male rats with ethanolic extracts of nutmeg, providing some support for the use of nutmeg as an aphrodisiac. Eugenol may be responsible for some of the aphrodisiac effect because of its vasodilatory and smooth muscle relaxant properties.(16, 17)

Clinical data

Despite anecdotal reports of aphrodisiac effects, clinical studies are lacking.


The National Cancer Institute has screened the Myristicaceae plant family for activity against selected leukemia lines. Of the tested extracts, 18.8% exhibited antileukemia activity, and in vitro studies with methanol extract and myristicin have shown increased apoptosis and decreased leukemia and neuroblastoma cell proliferation.(18, 19, 20) Several older experiments reveal some action on enzymes involved with activation and detoxification of carcinogens.

Animal data

More recently, experiments have evaluated the radio- and cisplatin-induced hepatoprotective effects in mice.(21, 22, 23)

Clinical data

Clinical trials are lacking; however, in vitro studies have included isolated human splenocytes and other cell lines.(19, 22)

CNS effects

Animal data

The effects of nutmeg on the CNS are variable and reflect anticholinergic and CNS excitatory and depressant effects. Dopaminergic and serotonin pathways may be involved.(24, 25, 26, 27, 28) Anticonvulsant activity in mice has been demonstrated.(29, 30, 31) The chemical constituents responsible for the CNS effects appear to be myristicin, which is a hallucinogenic and weak monoamine oxidase (MAO) inhibitor, elemicin, safrole, and trimyristin (anxiogenic effects), with some components being structurally similar to serotonin agonists.(26, 32, 33, 34)

Clinical data

Nutmeg has long been known for its psychoactive properties of producing anxiety/fear and hallucinations; however, clinical studies are lacking.(24, 35, 36) Long-term nutmeg abuse has been reported.(35) Laboratory tests have detected nutmeg metabolites, which are reported to be unlike amphetamine derivatives.(37)


Nutmeg has shown insulin-like activity in vitro.(38) Inhibitory effects on protein tyrosine phosphate 1B, involved in insulin cellular signaling, have been demonstrated.(39)

Animal data

Serum glucose and lipid profiles improved in mice when mace lignan was administered.(40) In rabbits given an ethanolic extract of nutmeg, total and low-density lipoprotein (LDL) cholesterol and triglyceride were reduced; however, high-density lipoprotein levels were not changed.(41)

Peripheral neuropathy

Clinical data

The updated American Academy of Neurology practice guideline summary for oral and topical treatment of painful diabetic polyneuropathy (2021) concluded that nutmeg extract is possibly no more likely than placebo to improve pain (low).(101)

Other effects

Screening and in vitro experiments in nutmeg components demonstrated ultraviolet-protectant effects and inhibition of melanin biosynthesis.(65, 66) Anti-inflammatory and analgesic activities of nutmeg have been recorded in mice, as well as antithrombotic activity.(67, 68) Other studies document hepatoprotective properties(69) effects on osteoblast differentiation(70) and reduced acidity and volume of gastric secretion.(71, 72)


There are no clinical trials to support therapeutic dosing.

Consumption of nutmeg 1 to 2 mg/kg of body weight induced CNS effects. Toxic overdose occurred at 5 g.8, 32, 36

Pregnancy / Lactation

Generally recognized as safe when used in food as a flavoring agent. Nutmeg traditionally has been used as an abortifacient. Although this use has been largely discounted, it remains a persistent cause of nutmeg intoxication in women.2, 3, 4


Interactions with nutmeg and diazepam, ondansetron, or buspirone occurred in rats.(30) One death has been associated with concurrent ingestion of large amounts of nutmeg and flunitrazepam.(33) Weak MAO inhibitory properties have been noted for the compound myristicin.(25)

Adverse Reactions

Allergy, contact dermatitis, and asthma have been reported. The chemical constituents limonene and eugenol are contact allergens. Immunoglobulin E reactivity has been demonstrated in nutmeg and mace.73, 74


Acute psychosis and anticholinergic-like episodes caused by nutmeg ingestion, including inhalation via snorting, have been reported with a wide variety of symptoms. Effects occurred within 0.5 to 8 hours following ingestion and are characterized by cutaneous flushing, tachycardia, decreased salivation, GI symptoms (eg, nausea, vomiting, abdominal pain), fever, and CNS excitation with anxiety/fear; miosis or mydriasis are not considered to be reliable signs, as either may be present. There have been rare reports of shock, coma, and death. Treatment is supportive, with the use of antipsychotic therapy when necessary.24, 25, 32, 35, 36, 100

The cytotoxic and apoptotic effects of myristicin have been explored. Cell viability was reduced by exposure to myristicin in a dose- and time-dependent manner.20 Myristic acid found in nutmeg, as in many other plant and animal fats, is a key component of human cellular biochemistry. It is recognized by the US Food and Drug Administration as safe when used as a flavoring agent or food-additive and is of low acute toxicity in rodent studies.75 Safrole, a minor component of the oil, promoted hepatocarcinomas in mice.76, 77, 78



This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

More about nutmeg

1. Myristica fragrans Houtt. USDA, NRCS. 2010. The PLANTS Database ( ). The National Plant Data Center, Baton Rouge, LA 70874-4490 USA.
2. De Milto L, Frey RJ. Nutmeg. In: Longe JL, project ed. Gale Encyclopedia of Alternative Medicine. Vol 3. 2nd ed. Detroit, MI: Thomson Gale; 2005:1461-1463.
3. Van Gils C, Cox PA. Ethnobotany of nutmeg in the Spice Islands. J Ethnopharmacol. 1994;42(2):117-124.8072304
4. Ernst E. Herbal medicinal products during pregnancy: are they safe? BJOG. 2002;109(3):227-235.11950176
5. Spricigo CB, Pinto LT, Bolzan A, Novais AF. Extraction of essential oil and lipids from nutmeg by liquid carbon dioxide. J Supercritical Fluids. 1999;15:253-259.
6. Dorman HJ, Figueiredo AC, Barroso JG, Deans SG. In vitro evaluation of antioxidant activity of essential oils and their components. Flavour Fragr J. 2000;15:12-16.
7. Shan B, Cai YZ, Sun M, Corke H. Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J Agric Food Chem. 2005;53(20):7749-7759.16190627
8. Hallström H, Thuvander A. Toxicological evaluation of myristicin. Nat Toxins. 1997;5(5):186-192.9496377
9. Su L, Yin JJ, Charles D, Zhou K, Moore J, Yu L. Total phenolic contents, chelating capacities, and radical-scavenging properties of black peppercorn, nutmeg, rosehip, cinnamon and oregano leaf. Food Chem. 2005.
10. Valderrama JC. Distribution of flavonoids in the Myristicaceae. Phytochemistry. 2000;55(6):505-511.11130660
11. Duan L, Tao HW, Hao XJ, Gu QQ, Zhu WM. Cytotoxic and antioxidative phenolic compounds from the traditional Chinese medicinal plant, Myristica fragrans. Planta Med. 2009;75(11):1241-1245.19326328
12. Orabi KY, Mossa JS, el-Feraly FS. Isolation and characterization of two antimicrobial agents from mace (Myristica fragrans). J Nat Prod. 1991;54(3):856-859.1955885
13. Zacchino SA, Badano H. Enantioselective synthesis and absolute configuration assignment of erythro-(3,4,5 trimethoxy-7hydroxy-1'allyl-2',6'-dimethoxy)-8.0.4'-neolignan from mace (Myristica fragrans). J Nat Prod. 1988;51:1261.
14. Kasahara H, Miyazawa M, Kameoka H. Absolute configuration of 8-o-4'-neolignans from Myristica fragrans. Phytochemistry. 1995;40:515-517.
15. Kwon HS, Kim MJ, Jeong HJ, et al. Low-density lipoprotein (LDL)-antioxidant lignans from Myristica fragrans seeds. Bioorg Med Chem Lett. 2008;18(1):194-198.17998162
16. Tajuddin S, Ahmad S, Latif A, Qasmi IA. Aphrodisiac activity of 50% ethanolic extracts of Myristica fragrans Houtt. (nutmeg) and Syzygium aromaticum (L) Merr. & Perry. (clove) in male mice: a comparative study. BMC Complement Altern Med. 2003;3:6.14567759
17. Tajuddin, Ahmad S, Latif A, Qasmi IA, Amin KM. An experimental study of sexual function improving effect of Myristica fragrans Houtt. (nutmeg). BMC Complement Altern Med. 2005;5:16.16033651
18. Cragg GM, Newman DJ, Yang SS. Natural product extracts of plant and marine origin having antileukemia potential. The NCI experience. J Nat Prod. 2006;69(3):488-498.16562862
19. Chirathaworn C, Kongcharoensuntorn W, Dechdoungchan T, et al. Myristica fragrans Houtt. methanolic extract induces apoptosis in a human leukemia cell line through SIRT1 mRNA downregulation. J Med Assoc Thai. 2007;90(11):2422-2428.18181330
20. Lee BK, Kim JH, Jung JW, et al. Myristicin-induced neurotoxicity in human neuroblastoma SK-N-SH cells. Toxicol Lett. 2005;157(1):49-56.15795093
21. Sohn JH, Han KL, Kim JH, Rukayadi Y, Hwang JK. Protective Effects of macelignan on cisplatin-induced hepatotoxicity is associated with JNK activation. Biol Pharm Bull. 2008;31(2):273-277.18239286
22. Checker R, Chatterjee S, Sharma D, et al. Immunomodulatory and radioprotective effects of lignans derived from fresh nutmeg mace (Myristica fragrans) in mammalian splenocytes. Int Immunopharmacol. 2008;8(5):661-669.18387508
23. Sharma M, Kumar M. Radioprotection of Swiss albino mice by Myristica fragrans houtt. J Radiat Res (Tokyo). 2007;48(2):135-141.17314471
24. Forrester MB. Nutmeg intoxication in Texas, 1998-2004. Hum Exp Toxicol. 2005;24(11):563-566.16323572
25. Sangalli BC, Chiang W. Toxicology of nutmeg abuse. J Toxicol Clin Toxicol. 2000;38(6):671-678.11185977
26. El-Alfy AT, Wilson L, ElSohly MA, Abourashed EA. Towards a better understanding of the psychopharmacology of nutmeg: Activities in the mouse tetrad assay. J Ethnopharmacol. 2009;126(2):280-286.19703539
27. Dhingra D, Parle M, Kulkarni SK. Comparative brain cholinesterase-inhibiting activity of Glycyrrhiza glabra, Myristica fragrans, ascorbic acid, and metrifonate in mice. J Med Food. 2006;9(2):281-283.16822217
28. Dhingra D, Sharma A. Antidepressant-like activity of n-hexane extract of nutmeg (Myristica fragrans) seeds in mice. J Med Food. 2006;9(1):84-89.16579733
29. Sonavane GS, Palekar RC, Kasture VS, Kasture SB. Anticonvulsant and behavioural actions of Myristica fragrans seeds. Indian J Pharm Sci. 2002;34:332-338.
30. Sonavane GS, Sarveiya V, Kasture V, Kasture SB. Behavioural actions of Myristica fragrans seeds. Indian J Pharm Sci. 2001;33:417-424.
31. Wahab A, Ul Haq R, Ahmed A, Khan RA, Raza M. Anticonvulsant activities of nutmeg oil of Myristica fragrans. Phytother Res. 2009;23(2):153-158.19067329
32. Demetriades AK, Wallman PD, McGuiness A, Gavalas MC. Low cost, high risk: accidental nutmeg intoxication. Emerg Med J. 2005;22(3):223-225.15735280
33. Stein U, Greyer H, Hentschel H. Nutmeg (myristicin) poisoning — report on a fatal case and a series of cases recorded by a poison information centre. Forensic Sci Int. 2001;118(1):87-90.11343860
34. Sonavane GS, Sarveiya VP, Kasture VS, Kasture SB. Anxiogenic activity of Myristica fragrans seeds. Pharmacol Biochem Behav. 2002;71(1-2):239-244.11812528
35. Kelly BD, Gavin BE, Clarke M, Lane A, Larkin C. Nutmeg and psychosis. Schizophr Res. 2003;60(1):95-96.12505144
36. Brenner N, Frank OS, Knight E. Chronic nutmeg psychosis. J R Soc Med. 1993;86(3):179-180.8459391
37. Beyer J, Ehlers D, Maurer HH. Abuse of nutmeg (Myristica fragrans Houtt.): studies on the metabolism and the toxicologic detection of its ingredients elemicin, myristicin, and safrole in rat and human urine using gas chromatography/mass spectrometry. Ther Drug Monit. 2006;28(4):568-575.16885726
38. Broadhurst CL, Polansky MM, Anderson RA. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem. 2000;48(3):849-852.10725162
39. Yang S, Na MK, Jang JP, et al. Inhibition of protein tyrosine phosphatase 1B by lignans from Myristica fragrans. Phytother Res. 2006;20(8):680-682.16752372
40. Han KL, Choi JS, Lee JY, et al. Therapeutic potential of peroxisome proliferators—activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes. Diabetes. 2008;57(3):737-745.18065517
41. Rani P, Khullar N. Antimicrobial evaluation of some medicinal plants for their anti-enteric potential against multi-drug resistant Salmonella typhi. Phytother Res. 2004;18(8):670-673.15476301
42. Shinohara C, Mori S, Ando T, Tsuji T. Arg-gingipain inhibition and anti-bacterial activity selective for Porphyromonas gingivalis by malabaricone C. Biosci Biotechnol Biochem. 1999;63(8):1475-1477.10501006
43. Yanti, Rukayadi Y, Kim KH, Hwang JK. In vitro anti-biofilm activity of macelignan isolated from Myristica fragrans Houtt. against oral primary colonizer bacteria. Phytother Res. 2008;22(3):308-312.17926328
44. Smith-Palmer A, Stewart J, Fyfe L. Influence of subinhibitory concentrations of plant essential oils on the production of enterotoxins A and B and alpha-toxin by Staphylococcus aureus. J Med Microbiol. 2004;53(pt 10):1023-1027.15358826
45. Smith-Palmer A, Stewartt J, Fyfe L. Inhibition of listeriolysin O and phosphatidylcholine-specific production in Listeria monocytogenes by subinhibitory concentrations of plant essential oils. J Med Microbiol. 2002;51(7):567-574.12132773
46. Singh G, Marimuthu P, DeHeluani CS, Catalan C. Antimicrobial and antioxidant potentials of essential oil and acetone extract of Myristica fragrans Houtt. (aril part). J Food Sci. 2005;70:141-148.
47. Chung JY, Choo JH, Lee MH, Hwang JK. Anticariogenic activity of macelignan isolated from Myristica fragrans (nutmeg) against Streptococcus mutans. Phytomedicine. 2006;13(4):261-266.16492529
48. Takikawa A, Abe K, Yamamoto M, et al. Antimicrobial activity of nutmeg against Escherichia coli O157. J Biosci Bioeng. 2002;94(4):315-320.16233309
49. De M, Krishna De A, Banerjee AB. Antimicrobial screening of some Indian spices. Phytother Res. 1999;13(7):616-618.10548758
50. Gonçalves JL, Lopes RC, Oliveira DB, et al. In vitro anti-rotavirus activity of some medicinal plants used in Brazil against diarrhea. J Ethnopharmacol. 2005;99(3):403-407.15876501
51. Narasimhan B, Dhake AS. Antibacterial principles from Myristica fragrans seeds. J Med Food. 2006;9(3):395-399.17004905
52. Firouzi R, Shekarforoush SS, Nazer AH, et al. Effects of essential oils of oregano and nutmeg on growth and survival of Yersinia enterocolitica and Listeria monocytogenes in barbecued chicken. J Food Prot. 2007;70(11):2626-2630.18044446
53. O'Mahony R, Al-Khtheeri H, Weerasekera D, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol. 2005;11(47):7499-7507.16437723
54. Mahady GB, Pendland SL, Stoia A, et al. In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res. 2005;19(11):988-991.16317658
55. Sridhar SR, Rajagopal RV, Rajavel R, Masilamani S, Narasimhan S. Antifungal activity of some essential oils. J Agric Food Chem. 2003;51(26):7596-7599.14664513
56. Zacchino SA, López SN, Pezzenati GD, et al. In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes. J Nat Prod. 1999;62(10):1353-1357.10543891
57. Zacchino S, Rodríguez G, Pezzenati G, Orellana G, Enriz R, Gonzalez Sierra M. In vitro evaluation of antifungal properties of 8.O.4'-neolignans. J Nat Prod. 1997;60(7):659-662.9249968
58. Dew TP, Day AJ, Morgan MR. Xanthine oxidase activity in vitro: effects of food extracts and components. J Agric Food Chem. 2005;53(16):6510-6515.16076142
59. Tomaino A, Cimino F, Zimbalatti V, et al. Influence of heating on antioxidant activity and the chemical composition of some spice essential oils. Food Chem. 2005;89:549-554.
60. Kumaravelu P, Subramaniyam S, Dakshinamoorthy DP, Devaraj NS. The antioxidant effect of eugenol on Ccl,-induced erythrocyte damage in rats. J Nutr Biochem. 1996;7:23-28.
61. Tezuka Y, Irikawa S, Kaneko T, et al. Screening of Chinese herbal drug extracts for inhibitory activity on nitric oxide production and identification of an active compound of Zanthoxylum bungeanum. J Ethnopharmacol. 2001;77(2-3):209-217.11535366
62. Sohn JH, Han KL, Choo JH, Hwang JK. Macelignan protects HepG2 cells against tert-butylhydroperoxide-induced oxidative damage. Biofactors. 2007;29(1):1-10.17611289
63. Ho SC, Tsai TH, Tsai PJ, Lin CC. Protective capacities of certain spices against peroxynitrite-mediated biomolecular damage. Food Chem Toxicol. 2008;46(3):920-928.
64. Suganthi R, Rajamani S, Ravichandran MK, Anuradha CV. Effect of food seasoning spices mixture on biomarkers of oxidative stress in tissues of fructose-fed insulin-resistant rats. J Med Food. 2007;10(1):149-153.17472479
65. Cho Y, Kim KH, Shim JS, Hwang JK. Inhibitory effects of macelignan isolated from Myristica fragrans HOUTT. on melanin biosynthesis. Biol Pharm Bull. 2008;31(5):986-989.18451531
66. Anggakusuma, Yanti, Hwang JK. Effects of macelignan isolated from Myristica fragrans Houtt. on UVB-induced matrix metalloproteinase-9 and cyclooxygenase-2 in HaCaT cells. J Dermatol Sci. 2010;57(2):114-122.19914807
67. Olajide OA, Ajayi FF, Ekhelar AI, Awe SO, Makinde JM, Alada AR. Biological effects of Myristica fragrans (nutmeg) extract. Phytother Res. 1999;13(4):344-345.10404545
68. Ma J, Hwang YK, Cho WH, Han SH, Hwang JK, Han JS. Macelignan attenuates activations of mitogen-activated protein kinases and nuclear factor kappa B induced by lipopolysaccharide in microglial cells. Biol Pharm Bull. 2009;32(6):1085-1090.19483320
69. Morita T, Jinno K, Kawagishi H, et al. Hepatoprotective effect of myristicin from nutmeg (Myristica fragrans) on lipopolysaccharide/d-galactosamine-induced liver injury. J Agric Food Chem. 2003;51(6):1560-1565.12617584
70. Lee SU, Shim KS, Ryu SY, Min YK, Kim SH. Machilin A isolated from Myristica fragrans stimulates osteoblast differentiation. Planta Med. 2009;75(2):152-157.19096999
71. Jan M, Faqir F, Hamida, Mughal MA. Comparison of effects of extract of Myristica fragrans and verapamil on the volume and acidity of carbachol induced gastric secretion in fasting rabbits. J Ayub Med Coll Abbottabad. 2005;17(2):69-71.16092656
72. Jan M, Faqir F, Qureshi H, Malik SA, Mughal MA. Evaluation of effects of extract from seeds of Myristica fragrans on volume and acidity of stimulated gastric secretion, liver and kidney function. J Postgrad Med Inst. 2004;18:644-650.
73. Brancaccio RR, Alvarez MS. Contact allergy to food. Dermatol Ther. 2004;17(4):302-313.15327475
74. Schöll I, Jensen-Jarolim E. Allergenic potency of spices: hot, medium hot, or very hot. Int Arch Allergy Immunol. 2004;135(3):247-261.15528928
75. Burdock GA, Carabin IG. Safety assessment of myristic acid as a food ingredient. Food Chem Toxicol. 2007;45(4):517-529.17141389
76. Miller EC, Swanson AB, Phillips DH, Fletcher TL, Liem A, Miller JA. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res. 1983;43(3):1124-1134.6825084
77. De Vincenzi M, Silano M, Stacchini P, Scazzocchio B. Constituents of aromatic plants: I. Methyleugenol. Fitoterapia. 2000;71(2):216-221.10727828
78. Barceloux DG. Nutmeg (Myristica fragrans Houtt.). Dis Mon. 2009;55(6):373-379.19446681
79. Bhamarapravati S, Pendland SL, Mahady GB. Extracts of spice and food plants from Thai traditional medicine inhibit the growth of the human carcinogen Helicobacter pylori. In Vivo. 2003;17(6):541-544.14758718
100. Beckerman B, Persaud H. Nutmeg overdose: spice not so nice. Complement Ther Med. 2019;46:44-46.31519286
101. Price R, Smith D, Franklin G, et al. Oral and topical treatment of painful diabetic polyneuropathy: Practice guideline update summary: Report of the AAN guideline subcommittee. Neurology. 2022;98(1):31-43. doi:10.1212/WNL.000000000001303834965987

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.